α2-Adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat

Psychopharmacology

Volumn 124, Issue 4, 1996, Pages 347-354

  Camacho, Fernando ^a   Smith, Craig P ^a   Vargas, Hugo M ^a   Winslow, James T ^a  

^a Neuroscience Therapeutic Domain   (United States)

Author keywords

Acetylcholinesterase inhibitor; Alzheimers' disease; Rat; 2 Adrenoceptor antagonists

Indexed keywords

7 CHLORO 3,4,5,6 TETRAHYDRO 4 METHYL 2 VINYLTHIENO[4,3,2 EF][3]BENZAZEPINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; GALANTAMINE; HEPTYLPHYSOSTIGMINE; IDAZOXAN; N [2 (1,3,4,6,7,12B HEXAHYDRO 2' OXOSPIRO[2H BENZOFURO[2,3 A]QUINOLIZINE 2,4' IMIDAZOLIDIN] 3' YL)ETHYL]METHANESULFONAMIDE; P 86 7480; PRESYNAPTIC RECEPTOR; TACRINE; UNCLASSIFIED DRUG; VELNACRINE; YOHIMBINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; NONHUMAN; NORADRENERGIC SYSTEM; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AVOIDANCE LEARNING; BENZAZEPINES; CHOLINESTERASE INHIBITORS; DRUG SYNERGISM; GALANTAMINE; IDAZOXAN; MALE; PHYSOSTIGMINE; RATS; RATS, SPRAGUE-DAWLEY; TACRINE; YOHIMBINE;

EID: 0029970479     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02247440     Document Type: Article

References (61)

1. Abercrombie ED, Keller RWJ, Zigmond MJ (1988) Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 27:897-904
2. Arnsten AF, Cai JX (1993) Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: indirect effects of yohimbine versus direct effects of clonidine. Neurobiol Aging 14[6]:597-603
3. Arnsten AF, Contant TA (1992) Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacology 108[1-2]:159-169
4. Arnsten AF, Leslie FM (1991) Behavioral and receptor binding analysis of the alpha 2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an alpha 2-adrenoceptor subtype. Neuropharmacology 30[12A]:1279-1289
5. Arnsten AF, Goldman-Rakic PS (1985) Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230[4731]:1273-1276
6. Bartus RT, Dean R3, Sherman KA, Friedman E, Beer B (1981) Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiol Aging 2[21]:105-111
7. Bartus BT, Dean III RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-416
8. Beller SA, Overall JE, Swann AC (1985) Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Psychopharmacology 87[2]: 147-151
9. Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32:164-168
10. Bondi MW, Salmon DP, Butters NM (1994) Neuropsychological features of memory disorders in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 41-64
11. Cai JX, Ma YY, Xu L, Hu XT (1993) Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine. Brain Res 614[1-2]: 191-196
12. Clineschmidt BV, Pettibone DJ, Lotti VJ, Hucker HB, Sweeney BM, Reiss DR, Lis EV, Huff JR, Vacca J (1988) A peripherally acting alpha-2 adrenoceptor antagonist: L-659, 066. J Pharmacol Exp Ther 245[1]:32-40
13. Connor DJ, Dietz S, Langlais PJ, Thai LJ (1992) Behavioral effects of concurrent lesions of the nucleus basalis magnocellularis and the dorsal noradrenergic bundle. Exp Neurol 116[1]:69-75
14. Costa E, Panula P, Thompson HK, Cheny DL (1983) The transsynaptic regulation of the septo-hippocampal neurons. Life Sci 32:165-179
15. Coull JT (1994) Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs Aging 5[2]: 116-126
16. Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184-1190
17. Cuadra G, Giacobini E (1995) Coadministration of cholinesterase inhibitors and idazoxan: effects of neurotransmitters in rat cortex in vivo. J Pharmacol Exp Ther 273:230-240
18. Davis K, Thai L, Gamzu E (1992) A double-blind placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Eng J Med 327:1253-1259
19. Davis KL, Haroutunian V (1993) Strategies for the treatment of Alzheimer's disease. Neurology 43[8 Suppl. 4]:S52-S55
20. Decker M (1992) Cholinergic/adrenergic interactions and memory. In: Levin ED, Decker MW, Larry LB (eds) Neurotransmitter interactions and cognitive function. Birkhauser, Boston, MA, pp 78-90
21. Decker MW, Gallagher M (1987) Scopolamine-disruption of radial arm maze performance: modification by noradrenergic depletion. Brain Res 417[1]:59-69
22. Decker MW, McGaugh JL (1989) Effects of concurrent manipulations of cholinergic and noradrenergic function on learning and retention in mice. Brain Res 477[1-2]:29-37
23. Decker MW, McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7[2]:151-168
24. Decker MW, Gill TM, McGaugh JL (1990) Concurrent muscarinic and β-adrenergic blockade in rats impairs place-learning in a water maze and retention of inhibitory avoidance. Brain Res 513:81-85
25. Dekker AJ, Connor DJ, Thal LJ (1991) The role of cholinergic projections from the nucleus basalis in memory. Neurosci Biobehav Rev 15[2]:299-317
26. Dennis T, L'Heureux R, Carter C, Scatton B (1987) Presynaptic alpha-2-adrenoreceptors play a major role in the effects of idazoxan on cortical noradrenergic release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther 241:642-649
27. Devauges V, Sara SJ (1990) Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav Brain Res 39:19-28
28. Dunnett SB, Everitt BJ, Robbins TW (1991) The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14[11]: 494-501
29. Fibiger HC (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence [see comments]. Trends Neurosci 14[6]:220-223
30. Fibiger HC (1992) Cholinergic replacement strategies in Alzheimer's disease: the postsynaptic dilemma. Commentary on Dawson et al. "Pharmacological mechanisms and animal models of cognition. Behav Pharmacol 3:299-300
31. Flood JF, Smith GE, Cherkin A (1985) Hydergine enhances memory in mice. J Pharmacol 3:39-49
32. Flood JF, Smith GE, Cherkin A (1988) Memory enhancement in mice: role of drug dose and training-testing interval. Pharmacol Biochem Behav 29[3]:635-639
33. Fulginiti S, Cancela LM (1983) Effect of naloxone and amphetamine on acquisition and memory consolidation of active avoidance responses in rats. Psychopharmacology 79[1]: 45-48
34. Gottfries CG, Adolfsson R, Acquilonius SM (1983) Biochemical changes in dementia disorders of the Alzheimer type (AD/SDAT). Neurohiol Aging 4:261-271
35. Gower AJ (1987) Enhancement by secoverine and physostigmine of retention of passive avoidance response in mice. Psychopharmacology 91[3]:326-329
36. Grigoryan GA, Mitchell SN, Hodges H, Sinden JD, Gray JA (1994) Are the cognitive-enhancing effects of nicotine in the rat with lesions to the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system? Pharmacol Biochem Behav 49[3]:511-521
37. Haroutunian V, Kanof PD, Tsuboyama G, Davis KL (1990) Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats. Brain Res 507[2]: 261-266
38. Hieble JP, Sulpizio AC, Edwards R, Chapman H, Young P, Roberts S, Blackburn TP, Wood MD, Shah DH, Demarinis RM, Ruffolo Jr RR (1991) Additional evidence for functional subclassification of alpha-2 adrenoreceptors based on a new selective antagonist, SK&F 104856. J Pharmacol Exp Ther 259[2]:643-652
39. Introini-Collison IB, Miyazaki B, McGaugh JL ( 1991) Involvement of the amygdala in the memory-enhancing effects of clenbuterol. Psychopharmacology 104[4]:541-544
40. Introini-Collison I, Saghafi D, Novack GD, McGaugh JL (1992) Memory-enhancing effects of post-training dipivefrin and epinephrine: involvement of peripheral and central adrenergic receptors. Brain Res 572[1-2]:81-86
41. Martinez J Jr, Vasquez BJ, Rigter H, Messing RB, Jensen RA, Liang KC, McGaugh JL (1980) Attenuation of amphetamine-induced enhancement of learning by adrenal demedullation. Brain Res 195[2]:433-443
42. Mason ST (1979) Central noradrenergic-cholinergic interaction and locomotor behavior. Eur J Pharmacol 56:131-137
43. Mason ST, Fibiger HC (1979) Possible behavioral function for noradrenergic-acetylcholine interaction in brain. Nature 277: 396-397
44. Mesulam MM, Mufson EJ, Wainer BH, Levey AI (1983) Central cholinergic pathways in the rat: a review based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10:1185-1201
45. Moran PM, LeMaitre MH, Philouze V, Reymann JM, Allain H, Leonard BE (1992) Reversal of learning and memory impairments following lesions of the nucleus basalis magnocellularis (NBM) by current noradrenergic depletion using DSP4 in the rat. Brain Res 595:327-333
46. Palmer AM, Francis PT, Bowen DM, Bennton JS, Neary D, Mann DMA, Snowden JS (1987) Catecholaminergic neurons assessed ante-mortem in Alzheimer's disease. Brain Res 414:365-375
47. Riekkinen PJ, Sirvio J, Riekkinen Jr P, Valjakka A, Jakala P, Koivisto E, Lammintausta R (1992) The role of the noradrenergic system in higher cerebral functions: experimental studies about the effects of noradrenergic modulation on electrophysiology and behavior. In: Levin ED, Decker MW, Larry LB (eds) Neurotransmitter interactions and cognitive function. Birkhauser, Boston, MA, pp91-102
48. Riekkinen P Jr, Riekkinen M, Sirvio J (1993) Cholinergic drugs regulate passive avoidance performance via the amygdala. J Pharmacol Exp Ther 267:1484-1492
49. Routledge C, Marsden CA (1987) Comparison of the effects of selected drugs on release of hypothalamic adrenaline and noradrenaline measured in vivo. Brain Res 426:103-111
50. Santucci AC, Haroutunian V, Davis KL (1991) Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats. Clin Neuropharmacol 14[1]: S1-S8
51. Sara SJ (1989) Noradrenergic-cliolinergic interaction: its possible role in memory dysfunction associated with senile dementia. Arch Gerontol Geriatr Suppl 1:99-108
52. Sara SJ, Devauges V (1989) Idazoxan, an α-2 antagonist, facilitates memory retrieval in the rat. Behav Neural Biol 51:401-411
53. Sara SJ, Vankov A, Herve A (1994) Locus coeruleus-evoked responses in behaving rats. A clue to the role of noradrenaline in memory. Brain Res Bull 35[5-6]:457-465
54. Selden NR, Cole BJ, Everitt BJ, Robbins TW (1990) Damage to ceruleo-cortical noradrenergic projections impairs locally cued but enhances spatially cued water maze acquisition. Behav Brain Res 39[1]:29-51
55. Shimohama S, Taniguchi T, Fujiwara M, Kameyama M (1986) Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia. J Neurochem 47[4]:1294-1301
56. Smith AP, Wilson SJ, Glue P et al. (1992) The effects and after effects of the 22-adrenergic antagonist idazoxan on mood, memory, and attention in normal volunteers. J Psychopharmacol 6: 376-381
57. Soetens E, D'Hooge R, Hueting JE (1993) Amphetamine enhances human-memory consolidation. Neurosci Lett 161[1]:9-12
58. Terry RD, Masliah E, Hansen LA (1994) Structural basis of the cognitive alterations in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 179-196
59. Venault P, Jacquot E, Save E, Sara S, Chapouthier G (1993) Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice. Life Sci 52[7]:639-645
60. Waterhouse BD, Moises HC, Woodward DJ (1981) Alpha-receptor-mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine. Neuropharmacology 20:907-920
61. Whitehouse PJ (1993) Cholinergic therapy in dementia. Acta Neurol Scan 88[Suppl. 149]:42-45